SHARE @ Advocate Health - Midwest - Scientific Day: Outcomes in Patients With Major Postprocedural Bleeding After Transcatheter Edge-to-Edge Repair of the Mitral Valve
 

Affiliations

Aurora St. Luke's Medical Center

Abstract

Background/Significance:

Real-world outcomes in patients with major post-procedure bleeding after mitral transcatheter edge-to-edge repair (TEER) from a large national database are unknown.

Purpose:

To study major bleeding outcomes in patients undergoing mitral TEER in order to implement and improve bleeding mitigation strategies.

Methods:

We used the National Inpatient Sample from 2013 to 2020 in our study. ICD-9 and ICD-10 codes were used to identify our study population. Linear and logistic regression were used to obtain unadjusted and adjusted estimates. Major bleeding was defined by any bleeding requiring blood transfusion after TEER.

Results:

Of 43,920 patients with mean age (SE) of 77 (0.13) years, 46% were females. Of these, 2156 (4.9%), had major bleeding requiring blood transfusion. Bleeding rates decreased significantly (P-trend < 0.001) from 21% in 2013 to 4% in 2020. Major bleeding was associated with increased in-hospital mortality on both unadjusted (OR 6.3, P < 0.001) and risk-adjusted (AOR 4.12, P < 0.001) analyses. It was also independently associated with an increased length of stay and cost on both unadjusted and risk adjusted analysis.

Conclusion:

Major bleeding is associated with worse outcomes in patients undergoing mitral TEER. Decreasing trends in these bleeding rates over time shown in our study are encouraging and continued efforts to reduce bleeding rates are needed to further improve these outcomes.

Presentation Notes

Presented at Scientific Day; May 21, 2025; Park Ridge, IL.

Full Text of Presentation

wf_yes

Document Type

Poster


 

Open Access

Available to all.

Share

COinS
 
May 21st, 11:41 AM May 21st, 11:41 AM

Outcomes in Patients With Major Postprocedural Bleeding After Transcatheter Edge-to-Edge Repair of the Mitral Valve

Background/Significance:

Real-world outcomes in patients with major post-procedure bleeding after mitral transcatheter edge-to-edge repair (TEER) from a large national database are unknown.

Purpose:

To study major bleeding outcomes in patients undergoing mitral TEER in order to implement and improve bleeding mitigation strategies.

Methods:

We used the National Inpatient Sample from 2013 to 2020 in our study. ICD-9 and ICD-10 codes were used to identify our study population. Linear and logistic regression were used to obtain unadjusted and adjusted estimates. Major bleeding was defined by any bleeding requiring blood transfusion after TEER.

Results:

Of 43,920 patients with mean age (SE) of 77 (0.13) years, 46% were females. Of these, 2156 (4.9%), had major bleeding requiring blood transfusion. Bleeding rates decreased significantly (P-trend < 0.001) from 21% in 2013 to 4% in 2020. Major bleeding was associated with increased in-hospital mortality on both unadjusted (OR 6.3, P < 0.001) and risk-adjusted (AOR 4.12, P < 0.001) analyses. It was also independently associated with an increased length of stay and cost on both unadjusted and risk adjusted analysis.

Conclusion:

Major bleeding is associated with worse outcomes in patients undergoing mitral TEER. Decreasing trends in these bleeding rates over time shown in our study are encouraging and continued efforts to reduce bleeding rates are needed to further improve these outcomes.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.